<HashMap><database>GEO</database><file_versions><headers><Content-Type>application/xml</Content-Type></headers><body><files><Other>ftp://ftp.ncbi.nlm.nih.gov/geo/series/GSE316nnn/GSE316440/</Other></files><type>primary</type></body><statusCodeValue>200</statusCodeValue><statusCode>OK</statusCode></file_versions><scores/><additional><omics_type>Transcriptomics</omics_type><species>Mus musculus</species><gds_type>Expression profiling by high throughput sequencing</gds_type><full_dataset_link>https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE316440</full_dataset_link><repository>GEO</repository><entry_type>GSE</entry_type></additional><is_claimable>false</is_claimable><name>Transcriptomic profiling of epigenetic regulators and metabolic reprogramming in human cholangiocarcinoma [liver]</name><description>To study the expression of epigenetic and metabolic genes in cholangiocarcinoma (CCA) tumor progression, CCA was induced in C57BL/6J mice by hydrodynamic tail vein injection (HTVI) of plasmids coding for Notch Intracellular Domain 1 (NICD1, 10 µg per mouse) in combination with myr-AKT (10 µg/mouse) and the sleeping beauty transposase (NICD1AKT). C57BL/6J mice without HTVI injection were used as healthy controls (C). Mice were sacrificed at 2 and 3 weeks to evaluate the expression landscape of epigenetic and metabolic genes in tumor progression. We then performed gene expression profiling using RNA-seq data from 3 mice per group.</description><dates><publication>2026/06/25</publication></dates><accession>GSE316440</accession><cross_references><GSM>GSM9453202</GSM><GSM>GSM9453203</GSM><GSM>GSM9453211</GSM><GSM>GSM9453212</GSM><GSM>GSM9453201</GSM><GSM>GSM9453206</GSM><GSM>GSM9453207</GSM><GSM>GSM9453204</GSM><GSM>GSM9453205</GSM><GSM>GSM9453208</GSM><GSM>GSM9453209</GSM><GSM>GSM9453210</GSM><GPL>30172</GPL><GSE>316440</GSE><taxon>Mus musculus</taxon><PMID>[42326014]</PMID></cross_references></HashMap>